SummitTX Capital’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$835K Buy
+4,336
New +$467K 0.02% 518

Other funds holding MRNA

SummitTX Capital's MRNA Position: Q3 2026 in Review

SummitTX Capital opened a new position in Moderna (MRNA) in Q3 2026: 4,336 shares worth $835K. The stake represents 0.02% of the portfolio and ranks #518 among its holdings.

1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • SummitTX Capital held 4,336 shares of Moderna worth $835K as of Q3 2026.
  • Moderna was a new SummitTX Capital position in Q3 2026.
  • Moderna made up 0.02% of SummitTX Capital's portfolio in Q3 2026, its #518 holding.
  • 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on SummitTX Capital's 13F filing for Q3 2026, filed 16 Nov 2026.